|
2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Suppliers list
|
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
| Company Name: |
ChemOrigin Pharm |
| Tel: |
15026428026 19002516454 |
| Email: |
ChemOrigin@126.com |
|
| | 2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Basic information |
| Product Name: | 2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- | | Synonyms: | 2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)-;2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (...;GS-1156(Elunonavir);GS-PI1;GS-1156;HIV protease inhibitor Elunonavir (GS-1156);Elunonavir | | CAS: | 2242428-57-3 | | MF: | C52H59F10N11O8 | | MW: | 1156.08 | | EINECS: | | | Product Categories: | | | Mol File: | 2242428-57-3.mol | ![2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Structure](CAS/20211123/GIF/2242428-57-3.gif) |
| | 2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | pka | 10.34±0.46(Predicted) |
| | 2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Usage And Synthesis |
| | 2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Preparation Products And Raw materials |
|